tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
PremiumThe FlyOragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
5M ago
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
Premium
The Fly
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
5M ago
Oragenics announces manufacturing agreement with Sterling Pharma for ONP-002
Premium
The Fly
Oragenics announces manufacturing agreement with Sterling Pharma for ONP-002
6M ago
Oragenics prices 800,000 shares of Preferred Stock at $25.00 in public offering
PremiumThe FlyOragenics prices 800,000 shares of Preferred Stock at $25.00 in public offering
6M ago
Oragenics trading halted, news pending
Premium
The Fly
Oragenics trading halted, news pending
6M ago
Oragenics trading resumes
Premium
The Fly
Oragenics trading resumes
7M ago
Oragenics Hosts Neurotrauma Medicine Webinar Presentation
PremiumCompany AnnouncementsOragenics Hosts Neurotrauma Medicine Webinar Presentation
8M ago
Oragenics announces approval to initiate Phase II concussion drug trial
Premium
The Fly
Oragenics announces approval to initiate Phase II concussion drug trial
8M ago
Oragenics Appoints Janet Huffman as CEO and CFO
Premium
Company Announcements
Oragenics Appoints Janet Huffman as CEO and CFO
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100